{"disease":{"id":"spasm","name":"Spasm","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"onabotulinumtoxina","indication_name":"Blepharospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."},{"drug_id":"tiotropium-bromide","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spiriva","generic_name":"TIOTROPIUM BROMIDE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic","quality_score":10,"revenue":"2500","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways."},{"drug_id":"tiotropium-bromide","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spiriva","generic_name":"TIOTROPIUM BROMIDE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic","quality_score":10,"revenue":"2500","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways."},{"drug_id":"fluticasone-propionate","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cutivate","generic_name":"FLUTICASONE PROPIONATE","company_name":"Teva Pharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":64,"revenue":"69.0","mechanism":""},{"drug_id":"incobotulinumtoxina","indication_name":"Blepharospasm in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."},{"drug_id":"terbutaline","indication_name":"Prevention and reversal of bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"belladonna-and-opium","indication_name":"Ureteral Spasm Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Belladonna and Opium","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Belladonna/opium rectal suppository combines atropine and morphine to relax smooth muscles and increase pain threshold, respectively."},{"drug_id":"eperisone","indication_name":"Spasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(+/-)-Eperisone","generic_name":"EPERISONE","company_name":"","drug_phase":"phase_3","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"eperisone","quality_score":36,"revenue":null,"mechanism":"Eperisone works by binding to the Sigma non-opioid intracellular receptor 1, which helps to reduce muscle spasms."},{"drug_id":"clazosentan","indication_name":"Prevention of cerebrovascular spasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pivlaz","generic_name":"CLAZOSENTAN","company_name":"Idorsia Pharmaceuticals Japan Ltd","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"depemokimab","indication_name":"acute bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exdensur","generic_name":"DEPEMOKIMAB","company_name":"Glaxosmithkline Llc","drug_phase":"marketed","molecular_target":"Histamine","drug_class":"","quality_score":51,"revenue":null,"mechanism":"Exdensur works by binding to histamine, preventing it from interacting with its receptors and reducing inflammation and airway constriction."},{"drug_id":"methocarbamol","indication_name":"Muscle Spasm with Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Robaxin","generic_name":"METHOCARBAMOL","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 1","drug_class":"Muscle Relaxant [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"formoterol","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"formoterol","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"salbutamol","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proventil","generic_name":"salbutamol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"salbutamol","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proventil","generic_name":"salbutamol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"salbutamol","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proventil","generic_name":"salbutamol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"salbutamol","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proventil","generic_name":"salbutamol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"beclomethasone","indication_name":"relief of acute bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qvar Redihaler","generic_name":"BECLOMETHASONE","company_name":"Norton Waterford","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"cromoglicic-acid","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intal","generic_name":"cromoglicic acid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G-protein coupled receptor 35","drug_class":"Mast Cell Stabilizer","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"fluticasone","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flonase","generic_name":"fluticasone propionate","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Inhaled/intranasal corticosteroid","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"albuterol","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ProAir","generic_name":"albuterol","company_name":"Generic (originally Allen & Hanburys/GSK)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"SABA (Short-acting beta-2 agonist)","quality_score":56,"revenue":null,"mechanism":"Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm."},{"drug_id":"albuterol","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ProAir","generic_name":"albuterol","company_name":"Generic (originally Allen & Hanburys/GSK)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"SABA (Short-acting beta-2 agonist)","quality_score":56,"revenue":null,"mechanism":"Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm."},{"drug_id":"albuterol","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ProAir","generic_name":"albuterol","company_name":"Generic (originally Allen & Hanburys/GSK)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"SABA (Short-acting beta-2 agonist)","quality_score":56,"revenue":null,"mechanism":"Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm."},{"drug_id":"albuterol","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ProAir","generic_name":"albuterol","company_name":"Generic (originally Allen & Hanburys/GSK)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"SABA (Short-acting beta-2 agonist)","quality_score":56,"revenue":null,"mechanism":"Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm."},{"drug_id":"indacaterol","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arcapta Neohaler","generic_name":"INDACATEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"indacaterol","indication_name":"Prevention of Bronchospasm with Chronic Bronchitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arcapta Neohaler","generic_name":"INDACATEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"indacaterol","indication_name":"Prevention of Bronchospasms with Emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arcapta Neohaler","generic_name":"INDACATEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"cromoglicate","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cromoglicate","company_name":"LEO Pharma","drug_phase":"discontinued","molecular_target":"Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"fasudil","indication_name":"Spasm of cerebral arteries","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FASUDIL","company_name":"","drug_phase":"marketed","molecular_target":"Rho-associated protein kinase 2","drug_class":"fasudil","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"codeine","indication_name":"Muscle Spasm with Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Codeine","generic_name":"codeine phosphate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Delta-type opioid receptor, Kappa-type opioid receptor, Mu-type opioid receptor","drug_class":"Opioid analgesic, Antitussive","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"carisoprodol","indication_name":"Muscle Spasm with Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Soma","generic_name":"CARISOPRODOL","company_name":"Mylan Speciality Lp","drug_phase":"marketed","molecular_target":"","drug_class":"Muscle Relaxant [EPC]","quality_score":59,"revenue":null,"mechanism":"Carisoprodol's mechanism for relieving acute musculoskeletal pain is unclear, but it involves altered interneuronal activity in the spinal cord and brain."},{"drug_id":"singulair","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Singulair","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"diazepam-2mg-encapsulated-tab","indication_name":"Relief of skeletal muscle spasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diazepam 2Mg encapsulated Tab","company_name":"The University of Hong Kong","drug_phase":"marketed","molecular_target":"GABA-A receptor (allosteric modulator)","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ephedrine","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akovaz","generic_name":"EPHEDRINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"Norepinephrine Releasing Agent","quality_score":52,"revenue":null,"mechanism":"Akovaz works by releasing norepinephrine, a natural chemical in the body that helps to relieve symptoms of respiratory and allergic conditions."},{"drug_id":"scopolamine-butylbromide","indication_name":"Gastric spasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Buscopan","generic_name":"scopolamine butylbromide","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"butylscopolamine","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"penthienate","indication_name":"Gastric spasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monodral","generic_name":"penthienate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"penthienate","quality_score":null,"revenue":null,"mechanism":"Monodral works by inhibiting the action of acetylcholine at muscarinic receptors in the gastrointestinal tract."},{"drug_id":"flixotide","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Flixotide","company_name":"Mundipharma Research Limited","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluticason","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluticason","company_name":"Creighton University","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"levalbuterol","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Levalbuterol","company_name":"University of Aleppo","drug_phase":"marketed","molecular_target":"beta 2 -adrenergic receptors","drug_class":"","quality_score":52,"revenue":null,"mechanism":"Levalbuterol activates beta 2 -adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscles."},{"drug_id":"levalbuterol","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Levalbuterol","company_name":"University of Aleppo","drug_phase":"marketed","molecular_target":"beta 2 -adrenergic receptors","drug_class":"","quality_score":52,"revenue":null,"mechanism":"Levalbuterol activates beta 2 -adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscles."},{"drug_id":"theophyllin","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"isoproterenol","indication_name":"Treatment of bronchospasm occurring during anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ISOPROTERENOL","company_name":"","drug_phase":"marketed","molecular_target":"beta-adrenergic receptors","drug_class":"Beta-adrenergic agonist","quality_score":80,"revenue":null,"mechanism":"Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors."},{"drug_id":"chlorzoxazone","indication_name":"Muscle Spasm with Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Parafon Forte Dsc","generic_name":"CHLORZOXAZONE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Nitric oxide synthase, endothelial","drug_class":"Muscle Relaxant [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ipratropium","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"ipratropium","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"isoproterenol","indication_name":"Treatment of bronchospasm during anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ISOPROTERENOL","company_name":"","drug_phase":"marketed","molecular_target":"beta-adrenergic receptors","drug_class":"Beta-adrenergic agonist","quality_score":80,"revenue":null,"mechanism":"Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors."},{"drug_id":"levosalbutamol","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xopenex","generic_name":"LEVOSALBUTAMOL","company_name":"Oak Pharms Inc","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":65,"revenue":null,"mechanism":"Xopenex works by activating the beta-2 adrenergic receptor, leading to bronchodilation and relaxation of airway smooth muscle."},{"drug_id":"incobotulinumtoxina","indication_name":"Blepharospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."},{"drug_id":"diprophylline","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"orciprenaline","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metaproterenol","generic_name":"orciprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"bitolterol","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tornalate","generic_name":"BITOLTEROL","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"bitolterol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"serevent","indication_name":"Bronchospasm Prevention with COPD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Serevent","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"serevent","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Serevent","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xopenex","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xopenex","company_name":"Phoenix Children's Hospital","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xopenex","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xopenex","company_name":"Phoenix Children's Hospital","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cromoglycate","indication_name":"Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cromoglycate","company_name":"Vishwajit Nimgaonkar, MD PhD","drug_phase":"phase_3","molecular_target":"Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"montelukast","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Singulair","generic_name":"montelukast","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2","drug_class":"Leukotriene receptor antagonist (LTRA)","quality_score":null,"revenue":null,"mechanism":"Leukotriene receptor antagonist (LTRA) that blocks CysLT1 receptors, reducing bronchoconstriction, mucus production, and airway inflammation."},{"drug_id":"levosalbutamol","indication_name":"Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xopenex","generic_name":"LEVOSALBUTAMOL","company_name":"Oak Pharms Inc","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":65,"revenue":null,"mechanism":"Xopenex works by activating the beta-2 adrenergic receptor, leading to bronchodilation and relaxation of airway smooth muscle."},{"drug_id":"albuterol-sulfate","indication_name":"Bronchospasm Treatment or Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALBUTEROL SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"albuterol-sulfate","indication_name":"Exercise-Induced Bronchospasm Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALBUTEROL SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"salmeterol-xinafoate","indication_name":"Prevention of Exercise-Induced Bronchospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SALMETEROL XINAFOATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":18,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"cosyntropin","indication_name":"Infantile spasms","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"COSYNTROPIN","company_name":"","drug_phase":"marketed","molecular_target":"MC2 receptor","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":66,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03505216","title":"Swiss Paediatric Airway Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT07135024","title":"Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5001,"lead_sponsor_name":"Gerrit A Schubert","has_results":false},{"nct_id":"NCT04538534","title":"Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Pr. Semir Nouira","has_results":false},{"nct_id":"NCT04671082","title":"Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1004,"lead_sponsor_name":"Neurana Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06906432","title":"Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT03427697","title":"Effect of VR and Accommdation Relax on Controlling Myopia in Children","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06125392","title":"Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Johannes Gutenberg University Mainz","has_results":false},{"nct_id":"NCT06089031","title":"Belgian Registry on Coronary Function Testing","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT05288361","title":"The DISCOVER INOCA Prospective Multi-center Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT05628948","title":"Vascular Lab Resource (VLR) Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT07211529","title":"Intraoperative Paravertebral Block and Postoperative Complications","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07449052","title":"Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03802565","title":"Tolperisone in Acute Muscle Spasm of the Back","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":415,"lead_sponsor_name":"Neurana Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07087522","title":"Impact of Preprocedural Stress Ball Use on Radial Artery Outcomes in Elective Coronary Angiography","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sakarya University","has_results":false},{"nct_id":"NCT07060820","title":"Association Between Radial Artery Access Point and Radial Artery Spasm","phase":"NA","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"Mersin Medicalpark Hastanesi","has_results":false},{"nct_id":"NCT04362527","title":"Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04998370","title":"Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury","phase":"","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05635994","title":"Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)","phase":"","overall_status":"UNKNOWN","enrollment_count":260,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT00118716","title":"A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04792944","title":"Brain Aneurysms: Utility of Cisternal Urokinase Irrigation","phase":"","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT05861765","title":"The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06962007","title":"Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Wonkwang University Hospital","has_results":false},{"nct_id":"NCT04691271","title":"Stellate Ganglion Block and Cerebral Vasospasm","phase":"NA","overall_status":"UNKNOWN","enrollment_count":202,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04842136","title":"Factors Affecting Patients With Myofascial Temporomandibular Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Hasan Kalyoncu University","has_results":false},{"nct_id":"NCT06480084","title":"Prevalence of EILO Among Children With Asthma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Medisch Spectrum Twente","has_results":false},{"nct_id":"NCT07293689","title":"PREcision MEDicine In Achalasia (PREMEDIA) - Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT07186933","title":"Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University General Hospital of Patras","has_results":false},{"nct_id":"NCT06893588","title":"Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Vesalio","has_results":false},{"nct_id":"NCT07305922","title":"Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT04598308","title":"EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Catharina Ziekenhuis Eindhoven","has_results":false},{"nct_id":"NCT06838559","title":"Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":182,"lead_sponsor_name":"University of Colombo","has_results":false},{"nct_id":"NCT02814565","title":"Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT05902676","title":"The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Izmir Ataturk Training and Research Hospital","has_results":false},{"nct_id":"NCT05216770","title":"Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":165,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT05150106","title":"Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor","phase":"","overall_status":"RECRUITING","enrollment_count":165,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT04317846","title":"Transradial Evaluation Study of Diameter Increase After Vasodilatory Drugs Administration.","phase":"NA","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"University of Lausanne Hospitals","has_results":false},{"nct_id":"NCT04512859","title":"Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06303349","title":"Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.","phase":"NA","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06560372","title":"Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital","phase":"NA","overall_status":"RECRUITING","enrollment_count":154,"lead_sponsor_name":"University Hospital Center of Martinique","has_results":false},{"nct_id":"NCT03193294","title":"CORonary MICrovascular Angina (CorMicA)","phase":"NA","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"NHS National Waiting Times Centre Board","has_results":false},{"nct_id":"NCT05377931","title":"Ocular and Cardiac Effects of Battle Ground","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT05272618","title":"Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Chonnam National University Hospital","has_results":false},{"nct_id":"NCT04766151","title":"Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"424 General Military Hospital","has_results":false},{"nct_id":"NCT06447688","title":"The Role of Verapamil in Radial Artery Spasm","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Mersin Medicalpark Hastanesi","has_results":true},{"nct_id":"NCT03042962","title":"Brain Networks in Dystonia","phase":"","overall_status":"RECRUITING","enrollment_count":141,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT03342118","title":"Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Keimyung University Dongsan Medical Center","has_results":false},{"nct_id":"NCT03216473","title":"Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT06863662","title":"Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Laboratorios Silanes S.A. de C.V.","has_results":false},{"nct_id":"NCT03876444","title":"Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":128,"lead_sponsor_name":"Suvasini Sharma","has_results":false},{"nct_id":"NCT05555134","title":"INHALATION CHAMBER MANAGEMENT IN PEDIATRICS: EFFICACY OF AN EDUCATIONAL INTERVENTION IN PATIENTS DIAGNOSED WITH BRONCHOSPASM AND THEIR FAMILY CAREGIVERS.","phase":"NA","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Puerta de Hierro University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}